Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | APAF1 | O14727 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | RAD52 | P43351 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | PGR | P06401 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29394041 | 1.00 | HTT (0.57) | HTTKDM4EAPAF1ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL29465194 | 0.98 | HTT (0.55) | HTTKDM4EAPAF1ALDH1A1LMNA | |
| Iodide SCHEMBL16107451 | 0.98 | HTT (0.55) | HTTKDM4EAPAF1ALDH1A1LMNA | |
| Bromide SCHEMBL29987617 | 0.98 | HTT (0.55) | HTTKDM4EAPAF1ALDH1A1LMNA | |
| Water SCHEMBL15375382 | 0.98 | HTT (0.55) | HTTKDM4EAPAF1ALDH1A1LMNA | |
| Bromide SCHEMBL17926315 | 0.98 | HTT (0.55) | HTTKDM4EAPAF1ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL17926382 | 0.98 | HTT (0.55) | HTTKDM4EAPAF1ALDH1A1LMNA | |
| Bromide SCHEMBL194547 | 0.98 | HTT (0.55) | HTTKDM4EAPAF1ALDH1A1LMNA | |
| Fluoride Ion SCHEMBL30213090 | 0.98 | HTT (0.55) | HTTKDM4EAPAF1ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL322540 | 0.98 | HTT (0.55) | HTTKDM4EAPAF1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122085568-A | Ion gel electrolyte composition capable of being subjected to room-temperature in-situ spontaneous polymerization, electrolyte and application | — | 2026-05-26 | — | — | CN | claimed |
| US-20250196021-A1 | METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2025-06-19 | — | — | US | claimed |
| US-20250036046-A1 | TRANSFER BELT AND IMAGE FORMING APPARATUS INCORPORATING TRANSFER BELT | RICOH COMPANY, LTD. (JP) | 2025-01-30 | — | — | US | claimed |
| EP-4498167-A1 | TRANSFER BELT AND IMAGE FORMING APPARATUS INCORPORATING TRANSFER BELT | Ricoh Company, Ltd. (JP) | 2025-01-29 | — | — | EP | claimed |
| EP-4470972-A1 | PROCESS FOR PRODUCING ONIUM SALTS OF BIS(FLUOROSULFONYL)IMIDE | SPECIALTY OPERATIONS FRANCE (FR) | 2024-12-04 | — | — | EP | claimed |
| CN-117285721-A | Carboxylated porous aromatic skeleton material and preparation method and application thereof | 合肥学院 | 2023-12-26 | — | — | CN | claimed |
| EP-3204977-B1 | ELECTROLYTE FOR RECHARGEABLE ELECTROCHEMICAL CELL | EOS ENERGY TECH HOLDINGS LLC (US) | 2023-12-20 | — | — | EP | claimed |
| EP-3835386-B1 | TWO COMPONENT (2K) CURABLE ADHESIVE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2023-11-15 | — | — | EP | claimed |
| CN-114787298-B | Two-component (2K) curable adhesive composition | 汉高股份有限及两合公司 | 2023-10-31 | — | — | CN | claimed |
| CN-116322077-A | Hole transport layer solution with photoactive layer passivation effect and preparation and application thereof | 上海钙蓝时代光电科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| EP-1641882-A1 | IONIC CONDUCTING GELS, PREPARATION METHOD THEREOF AND USE OF SAME | Centre National de la Recherche Scientifique (FR) | 2006-04-05 | — | — | EP | claimed |
| WO-2006031814-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | COMBIMATRIX CORPORATION (US) | 2006-03-23 | — | — | WO | claimed |
| WO-2006029788-A1 | METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-23 | — | — | WO | claimed |
| US-20050232981-A1 | Compositions capable of facilitating penetration across a biological barrier | CHIASMA, INC. | 2005-10-20 | — | — | US | claimed |
| WO-2005094785-A2 | COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER | CHIASMA, LTD. (IL) | 2005-10-13 | — | — | WO | claimed |
| US-20050136103-A1 | Transepithelial delivery of effectorsequentially coupled with a counter ion to the at least one effector and at least one pharmaceutically acceptable hydrophobic agent; translocation, encapsulation | CHIASMA, INC. | 2005-06-23 | — | — | US | claimed |
| US-20050058702-A1 | Compositions capable of facilitating penetration across a biological barrier | CHIASMA, INC. | 2005-03-17 | — | — | US | claimed |
| WO-2005007746-A1 | IONIC CONDUCTING GELS, PREPARATION METHOD THEREOF AND USE OF SAME | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2005-01-27 | — | — | WO | claimed |
| US-20040146549-A1 | Amino acid sequences capable of facilitating penetration across a biological barrier | CHIASMA, INC. | 2004-07-29 | — | — | US | claimed |
| EP-1362572-A1 | Cosmetic composition comprising at least one particular organic salt and its use for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment | L'OREAL (FR) | 2003-11-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136103-A1 | Transepithelial delivery of effectorsequentially coupled with a counter ion to the at least one effector and at least one pharmaceutically acceptable hydrophobic agent; translocation, encapsulation | CFTR, SLC47A1, SLC47A2 | HTT 677/4885KDM4E 4611/4885APAF1 1149/4885 |
| US-20050232981-A1 | Compositions capable of facilitating penetration across a biological barrier | MMP8, PGF, AQP1 | HTT 684/4885KDM4E 4876/4885APAF1 481/4885 |
| US-20040146549-A1 | Amino acid sequences capable of facilitating penetration across a biological barrier | SLC7A1, SLC1A5, SLC3A2 | HTT 366/4885KDM4E 4787/4885APAF1 787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.